Ian Pitfield
Direttore Tecnico/Scientifico/R&S presso GYROSCOPE THERAPEUTICS HOLDINGS PLC
Profilo
Ian Pitfield is a professional who has worked as the Head of Cell & Gene Therapy Medicine at GSK Plc from 1993 to 2016.
Currently, he is the Senior Vice President-Technical Operations at Gyroscope Therapeutics Holdings Plc since 2020.
Dr. Pitfield holds a doctorate degree from the University of Cambridge.
Posizioni attive di Ian Pitfield
| Società | Posizione | Inizio |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Direttore Tecnico/Scientifico/R&S | 01/07/2020 |
Precedenti posizioni note di Ian Pitfield
| Società | Posizione | Fine |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01/12/2016 |
Formazione di Ian Pitfield
| University of Cambridge | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GSK PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Ian Pitfield
